Media
Bill Abajian of EastGate Biotech Corp. to speak at the 2019 M&A Forum for Pharma, Biotech and Med Device to be held between August 12 – 14, 2019 in Philadelphia
June 12, 2019
Forum to focus on Innovative Partnership Opportunities for Product, Porfolio and Market Development
Read moreEastGate Biotech Announces Preparation to Initiate Phase III Clinical Trials on Insugin, its Liquid Insulin Mouth Rinse for Type 2 diabetes patients
May 15, 2019
Multi-Center Phase III trial planned for 2019
Read moreLink to interview with Ms. Anna Gluskin, CEO, Eastgate Biotech Corp. on Wall Street Analyzer
May 2, 2019
Link to the interview of Eastgate's CEO Ms. Anna Gluskin.
Read moreEastGate Biotech Announces Positive Phase II Clinical Results of its Innovative Liquid Insulin Mouth Rinse Solution for Type 2 Diabetes
April 24, 2019
Following a 3-month treatment, significant Hb1c Reduction was observed with administration of a single dose of Insugin two times a day
Read moreEastgate BioTech Corp (OTCBB: ETBI) Interview with CEO Anna Gluskin
April 10, 2019
Eastgate BioTech Corp (OTCBB: ETBI) Interview with CEO Anna Gluskin
Read morehttps://upticknewswire.com/interview-ceo-anna-gluskin-of-eastgate-biotech-corp-otc-etbi/
March 25, 2019
Interview: CEO Anna Gluskin of Eastgate Biotech Corp. (OTC: ETBI)
Read moreEastgate Biotech Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply
March 19, 2019
Alliance with MJ Biopharm of Mumbai, India positions the company to further its plans for SEA countries for its liquid insulin mouth rinse
Read moreEastGate Biotech Attends Arab Health Conference Seeking Additional Joint Venture Partnerships
January 30, 2019
EastGate Biotech to Showcase Insulin Products at the Dubai World Trade Centre
Read moreEastGate Biotech Appoints Additional Consultants in Preparation of Progressing Company Developments in 2019
December 19, 2018
Eastgate Biotech Corp.appointed key consultants Saul A. Mashaal, PhmB, MBA and Munaf Ali, PhD to assist in regulatory matters and manufacturing of the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients.
Read moreEastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr Lalit Upadhyay for Upcoming Initiatives
November 19, 2018
EastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr. Lalit Upadhyay for Upcoming Initiatives
Read more